Document Detail

[Nutrition and Phosphorus - New progress and problem - . Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction].
MedLine Citation:
PMID:  23023637     Owner:  NLM     Status:  In-Data-Review    
Hyperphosphatemia is the most common complication among patients with chronic kidney disease. Large scale observational studies have identified hyperphosphatemia as an independent risk factor for cardiovascular disease and mortality in hemodialysis patients. The combination therapy of dietary phosphate restriction and phosphate removal with dialysis treatment is still not enough to achieve the serum phosphate within the target. Thererfore, phosphate binders is necessary for many dialyzed patients with hyperphosphatemia. In this article, we will review the detail and development of phosphate binders and recommendation for clinical practice in hyperphosphatemia.
Shigeo Negi; Shintaro Yamanaka; Daisuke Koreeda; Mitsuru Yashiro; Takashi Shigematsu
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Clinical calcium     Volume:  22     ISSN:  0917-5857     ISO Abbreviation:  Clin Calcium     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9433326     Medline TA:  Clin Calcium     Country:  Japan    
Other Details:
Languages:  jpn     Pagination:  1557-66     Citation Subset:  IM    
Division of Nephrology, Department of Internal Medicine, Wakayama Medical University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  [Nutrition and Phosphorus - New progress and problem - . Phosphate sensing and osteocyte].
Next Document:  [Cinacalcet hydrochloride and phosphate metabolism].